Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Valeant Pharmaceuticals Intl (VRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,159,814
  • Shares Outstanding, K 348,710
  • Annual Sales, $ 8,724 M
  • Annual Income, $ 2,404 M
  • 36-Month Beta -0.38
  • Price/Sales 0.97
  • Price/Cash Flow 1.87
  • Price/Book 1.80
  • Price/Earnings ttm 6.12
  • Earnings Per Share ttm 3.96
  • Most Recent Earnings 0.89 on 05/08/18
  • Next Earnings Date 08/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 1.000 on 11/10/10
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 0.81
  • Number of Estimates 6
  • High Estimate 0.91
  • Low Estimate 0.71
  • Prior Year 1.05
  • Growth Rate Est. (year over year) -22.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.56 +3.72%
on 06/28/18
27.25 -14.13%
on 06/14/18
-3.46 (-12.88%)
since 06/13/18
3-Month
16.76 +39.62%
on 04/16/18
27.79 -15.80%
on 06/13/18
+6.25 (+36.44%)
since 04/13/18
52-Week
10.94 +113.89%
on 11/02/17
27.79 -15.80%
on 06/13/18
+6.11 (+35.34%)
since 07/13/17

Most Recent Stories

More News
International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities

MarketNewsUpdates.com News Commentary

VRX.TO : 30.80 (-3.33%)
EYC.VN : 0.170 (+3.03%)
EYEG : 0.43 (+2.38%)
EYCCF : 0.1369 (+12.21%)
STAA : 42.95 (-1.17%)
AGN : 191.00 (+1.60%)
VRX : 23.40 (-3.43%)
Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options

Investors in Valeant Pharmaceuticals (VRX) need to pay close attention to the stock based on moves in the options market lately.

VRX : 23.40 (-3.43%)
Drug Pricing in Focus Again as Trump Tweet Slams Pfizer

In a tweet, Trump says Pfizer and other U.S. drugmakers should be "ashamed" that they have raised drug prices for "no reason".

MYL : 33.02 (-0.27%)
MRK : 71.82 (+0.84%)
VRX : 23.40 (-3.43%)
PFE : 44.57 (+1.46%)
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%

PDUFA Date Set for February 25, 2019

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Valeant Announces Pricing Of Private Offering Of Notes

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that Valeant Pharmaceuticals International (the "Issuer"), the Company's wholly owned indirect subsidiary,...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that Valeant Pharmaceuticals International (the "Issuer"), the Company's wholly owned indirect subsidiary,...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference

Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
VRX Investor Alert: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors

Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE:VRX) that it is filling legal claims against the company for possible securities fraud violations committed by Valeant Pharmaceuticals...

VRX : 23.40 (-3.43%)
Valeant (VRX) Rallies on Earnings Beat in Q1, Raises View

Valeant's (VRX) first-quarter earnings topped estimates driven by growth in Bausch + Lomb/International segment and Salix businesses. The company also upped its view.

LGND : 203.01 (-3.73%)
AZN : 39.29 (+0.54%)
EXEL : 17.01 (+0.53%)
VRX : 23.40 (-3.43%)
Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference

Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade VRX with:

Business Summary

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients....

See More

Key Turning Points

2nd Resistance Point 24.80
1st Resistance Point 24.10
Last Price 23.40
1st Support Level 23.03
2nd Support Level 22.66

See More

52-Week High 27.79
Last Price 23.40
Fibonacci 61.8% 21.35
Fibonacci 50% 19.36
Fibonacci 38.2% 17.38
52-Week Low 10.94

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar